Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative | Zendy

MJ Milloy | Zendy; Evan Wood | Zendy; Thomas Kerr | Zendy; Robert S. Hogg | Zendy; Silvia Guillemi | Zendy; P. Richard Harrigan | Zendy; Julio Montaner | Zendy

Open Access

Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative

Author(s) -

MJ Milloy,

Evan Wood,

Thomas Kerr,

Robert S. Hogg,

Silvia Guillemi,

P. Richard Harrigan,

Julio Montaner

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ929

Subject(s) - medicine , viremia , treatment as prevention , human immunodeficiency virus (hiv) , drug resistance , viral load , drug , hiv drug resistance , lentivirus , antiretroviral therapy , immunology , intervention (counseling) , antiretroviral drug , virology , environmental health , viral disease , psychiatry , microbiology and biotechnology , biology

Although treatment-as prevention (TasP) is a new cornerstone of global human immunodeficiency virus (HIV)-AIDS strategies, its effect among HIV-positive people who use illicit drugs (PWUD) has yet to be evaluated. We sought to describe longitudinal trends in exposure to antiretroviral therapy (ART), plasma HIV-1 RNA viral load (VL) and HIV drug resistance during a community-wide TasP intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research